1700057K13Rik Inhibitors
1700057K13Rik, or TEX35, Inhibitors comprise a diverse range of compounds that could indirectly modulate the activity of TEX35. The primary mode of action of these inhibitors is to target various signaling pathways and cellular processes that TEX35 might be involved in. These inhibitors operate through mechanisms such as kinase inhibition, proteasome inhibition, and modulation of gene expression, reflecting the complexity of cellular signaling.
The development of inhibitors for a protein like TEX35 requires understanding the protein's role, its interactions with other cellular components, and its involvement in specific pathways. This process involves computational modeling for structural analysis, synthesis, and testing of compounds for their ability to interact with the protein or its associated pathways. Experimental validation, including cell-based assays and biochemical studies, is essential to confirm their efficacy and specificity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor, which has shown to disrupt kinase signaling pathways involving TEX35. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, which has shown to impact PI3K/Akt signaling pathways potentially linked with TEX35. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which has shown to influence cellular growth and autophagy pathways involving TEX35. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor, which has shown to affect gene expression processes that involve TEX35. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An ERK pathway inhibitor, which has shown to alter signaling pathways where TEX35 is active. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, which has shown to disrupt signaling pathways involving TEX35. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, which has shown to influence protein degradation pathways related to TEX35. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
A calcium channel blocker, which has shown to alter calcium signaling pathways involving TEX35. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor, which has shown to alter chromatin structure and gene expression related to TEX35. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor, which has shown to impact signaling pathways involving TEX35. | ||||||